Debate. Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction?

Author： Wagner TMU  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.13, Iss.5, 1998-05, pp. : 1125-1126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutations of the BRCA1 Gene in Hereditary Breast and Ovarian Cancer in the Czech Republic

By  

Medical Principles and Practice, Vol. 12, Iss. 1, 2003-01 ,pp. : 23-29

Karger

Access to resources Recommend Favorite

BRCA1 Gene Expression in Breast Cancer in Kuwait: Correlation with Prognostic Parameters

By  

Medical Principles and Practice, Vol. 14, Iss. 2, 2008-07 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

F175S Change and a Novel Polymorphism in Presenilin-1 Gene in Late-Onset Familial Alzheimer’s Disease

By  

European Neurology, Vol. 47, Iss. 4, 2002-05 ,pp. : 209-213

Karger

Access to resources Recommend Favorite

Lack of Association between an Intronic Polymorphism in the Presenilin-1 Gene and Sporadic Late-Onset Alzheimer Disease in Polish Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-04 ,pp. : 137-139

Karger

Access to resources Recommend Favorite

Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review

By BERMEJO-PÉREZ M J   MÁRQUEZ-CALDERÓN S   LLANOS-MÉNDEZ A  

British Journal of Radiology, Vol. 81, Iss. 963, 2008-03 ,pp. : 172-179

British Institute of Radiology

Access to resources Recommend Favorite